Frazier Management LLC Rocket Pharmaceuticals, Inc. Transaction History

Frazier Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$43.34 - $65.91 $7.28 Million - $11.1 Million	-168,000 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$23.3 - $59.57 $8.39 Million - $21.4 Million	-360,000 Reduced 68.18%	168,000 $9.21 Million
Q2 2020 Aug 04, 2020	BUY	$13.32 - $22.61 $4.24 Million - $7.19 Million	318,000 Added 151.43%	528,000 $11.1 Million
Q1 2020 May 13, 2020	BUY	$9.71 - $25.11 $2.04 Million - $5.27 Million	210,000 New	210,000 $2.93 Million

243

106M

268K

119K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $792M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frazier Management LLC with notifications on news.